TIA1E384KMUTATION

There is 1 paper on TIA1E384KMUTATION in aging research: none in people yet, 1 in cells.

Gene

1 paper studies it2 findings

See all 1 papers on TIA1E384KMUTATION

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Barndiabetesfonden and 6 more
  • Cells1

Effects

2

Insulin content and release

downin human cells1

1 study
  1. TIA1E384KMUTATION decreases insulin content and release in human cells (homozygous E384K TIA1 mutation versus wild-type).

    “a proinsulin-to-insulin processing defect, a decreased insulin content and release”

    Cellshomozygous E384K TIA1 mutation versus wild-typeEndoC-βH1 cells

    The Welander TIA1 mutation dedifferentiates insulin-producing cells: Reversal by a GLP-1 receptor agonist

    The Journal of biological chemistry

More on Insulin content and release

β-cell dedifferentiation

upin human cells1

1 study
  1. TIA1E384KMUTATION induces β-cell dedifferentiation in human cells (homozygous E384K TIA1 mutation).

    “It is concluded that the TIA1 E384K mutation, via increased MYC levels and cell proliferation rates, causes beta cell dedifferentiation.”

    Cellshomozygous E384K TIA1 mutationEndoC-βH1 cells

    The Welander TIA1 mutation dedifferentiates insulin-producing cells: Reversal by a GLP-1 receptor agonist

    The Journal of biological chemistry

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months